/Investor DB

Fonds de solidarité FTQ — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Abilityability.aiinJun 2024 · $18M

Ability.ai builds AI agents that automate repetitive, rule-based workflows across business functions like customer support, HR, marketing, sales, finance, and IT, which customers deploy on their own platform called Trinity.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSales TechSan Francisco, US

Eugene Vyborov(Founder and CEO)in

Co-investorsSID Venture Partners1991 VenturesAlexandria

Epitopeaepitopea.cominOct 2024

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.

AI & Machine LearningBiotechHealthtechMontreal, CA

Claude PerreaultPierre Thibault

Co-investorsAdvent Life SciencesCambridge Innovation CapitalCTI Life Sciences Fund L.P.adMare BioInnovations

Feldan Therapeuticsfeldan.cominSep 2024

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.

BiotechDeep TechMedical Devices

François-Thomas Michaud(Board Member & Chief Executive Officer)in

Co-investorsAsahi Kasei Corporate Venture CapitalGenesys CapitalLinearis VenturesZynext Ventures

Flare Systemsflare.ioin𝕏Dec 2024 · $30M

Flare provides a searchable, structured dataset of dark web forums, marketplaces, and Telegram channels for cybercrime investigations and threat intelligence.

AI & Machine LearningCybersecurityData & InfrastructureEnterprise SoftwareSaaS

Norman MenzinJohn WilliamsoninAlex Hooper(Founder)Colin Mierowsky(Founder)Daniel Cohen(Founder)Daniel Parekh-Hill(Founder)

Co-investorsLuge Capital20VC4Di CapitalANOBAKABase10 PartnersBorderless Venture+8 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.